Drugs & TargetsFree Bristol-Myers Squibb withdraws U.S. application for Opdivo + Yervoy in first-line lung cancer January 25, 2019Vol.45 No.04
Drugs & TargetsFree FDA finalizes policy on labeling for accelerated approval drugs January 25, 2019Vol.45 No.04
Drugs & TargetsFree FDA grants Illumina’s TruSight Assay Breakthrough Device designation January 25, 2019Vol.45 No.04
Drugs & TargetsFree Genmab initiates of FDA submission for expansion of daratumumab in multiple myeloma January 25, 2019Vol.45 No.04
Clinical RoundupFree Finasteride found to be safe, effective prevention for prostate cancer January 25, 2019Vol.45 No.04
Clinical RoundupFree Remote participation enables patients with ALK-positive lung cancer to enroll in study of treatment resistance January 25, 2019Vol.45 No.04
Clinical RoundupFree Servier & Taiho present Lonsurf data at ASCO 2019 GI Symposium January 25, 2019Vol.45 No.04
Clinical RoundupFree New test for esophageal cancer could save millions of lives January 25, 2019Vol.45 No.04
Clinical RoundupFree AbbVie’s Imbruvica fails late-stage pancreatic cancer study January 25, 2019Vol.45 No.04
